[Experiences with a Pseudomonas immunoglobulin in artificially respirated patients with Pseudomonas pneumonia at a surgical intensive care unit].
In a clinical trial, the efficacy of a Pseudomonas immunoglobulin was studied in ten ventilated patients suffering from Pseudomonas pneumonia. Compared to ten patients of a previous study who had received a polyvalent immunoglobulin (control group), patients treated with Pseudomonas immunoglobulin fared better with respect to clinical success and duration of treatment, the period of antibiotic treatment being significantly shorter than in the control group.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000627:therapeutic use; D007262:Infusions, Intravenous; D007362:Intensive Care Units; D008875:Middle Aged; D011014:Pneumonia / Q000628:therapy*; D011183:Postoperative Complications / Q000628:therapy*; D011552:Pseudomonas Infections / Q000628:therapy*; D011550:Pseudomonas aeruginosa / Q000276:immunology; D012121:Respiration, Artificial
D000900:Anti-Bacterial Agents; D007074:Immunoglobulin G
Erfahrungen mit einem Pseudomonas-Immunglobulin bei beatmeten Patienten mit Pseudomonas-Pneumonie auf einer chirurgischen Intensivstation.